Diagnostics 4.0: the medical laboratory in digital health.
Laboratory Medicine
digital health
digitalization
health bot
Journal
Clinical chemistry and laboratory medicine
ISSN: 1437-4331
Titre abrégé: Clin Chem Lab Med
Pays: Germany
ID NLM: 9806306
Informations de publication
Date de publication:
25 02 2019
25 02 2019
Historique:
received:
07
10
2018
accepted:
20
11
2018
pubmed:
12
12
2018
medline:
9
11
2019
entrez:
12
12
2018
Statut:
ppublish
Résumé
During recent years, the digital revolution has changed the face of societies including industrial production, economies and peoples' social lives. From these changes we may extrapolate the developments that digitization of health care will bring to medicine in general and laboratory medicine in particular. Disruptive technologies will fundamentally change the way laboratory tests are going to be ordered, carried out and interpreted in the future, and test results from various sources need to be curated to be of added value for the patient's condition. Wearables and implantables will quantify the concentrations for an unknown number of laboratory parameters, and the data will be stored in cloud services at the fingertips of the patient as the sovereign of his/her health care data. A 24/7 online availability of health services will strengthen predictive medicine and may enable a vastly improved preventive health care that is supported by deep-learning algorithms for clinical decision-making not only on behalf of the physician, but also the empowered patient (e.g. health bots). This will likely shift the current role of Laboratory Medicine as a central provider of diagnostic information from a "hidden champion" towards a higher visibility redefining the patient-physician-laboratory relationship. For example, accessing digital health data will allow Laboratory Medicine to more efficiently contribute to the medical dialog than is often the case today. From this perspective, this will require major readjustments in the way we execute our profession, and it will also need new concepts of education and continuous professional development.
Identifiants
pubmed: 30530888
doi: 10.1515/cclm-2018-1088
pii: cclm-2018-1088
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
343-348Références
Schumpeter JA. Capitalism, socialism and democracy (1949). London: George Routledge & Co., Taylor and Francis Group, 1976.
Creative destruction. Wikipedia, the free encyclopedia. https://en.wikipedia.org/wiki/Creative_destruction.
Rahman AA, Hamid UZ, Chin TA. Emerging technologies with disruption effect: a review. Perintis eJournal 2017;7:111–8.
YouTube. Steve Jobs – iPhone Introduction in 2007 (Complete). https://www.youtube.com/watch?v=9hUIxyE2Ns8.
YouTube. Ballmer Laughs at iPhone. https://www.youtube.com/watch?v=eywi0h_Y5_U.
Främling K. Tracking of material flow by an Internet-based product data management system. Tieke EDISTY Magazine 2002;1:24–5.
Huevio E, Grönvall J, Främling K. Tracking and tracing parcels using a distributed computing approach. In: Solem O, editor, Proceedings of the 14th Annual Conference for Nordic Researchers in Logistics (NOFOMA’2002). Trondheim, Norway, 2002:29–43.
Sarma S, Brock DL, Ashton K. The networked physical world. MIT Auto-ID Center White Paper. Cambridge, MA, USA: Massachusett Institute of Technology, 2000.
The difference engine: “chattering objects” Economist 2010. https://www.economist.com/blogs/babbage//2010/08/ internet_things.
US Energy Information Administration 2017. How many meters are installed in the United States and who has them? https://www.eia.gov/tools/faqs/faq.php?id=108&t=3.
Industry 4.0. Wikipedia. https://en.wikipedia.org/wiki/Industry_4.0#cite_note-2.
Lasi H, Kemper HG, Fettke P, Feld T, Hoffmann M. Industry 4.0. Bus Inf Syst Eng 2014;6:239–42.
Hermann M, Pentek T, Otto B. Design Principles for Industrie 4.0 Scenarios. In: 49th Hawaii International Conference on System Sciences. Piscataway, NJ, USA: IEEE, 2016. DOI: 10.1109/HICSS.2016.488.
Kagermann H, Wahlster W, Helbig J, eds. Recommendations for implementing the strategic initiative Industry 4.0: Final report of the Industrie 4.0 Working Group. 2013.
Airbnb. Wikipedia, the free encyclopedia. https://en.wikipedia.org/wiki/Airbnb.
Rifkin J. The Zero Marginal Cost Society: the internet of things, the collaborative commons and the eclipse of capitalism. New York: St. Martin’s Press, 2014.
Daniel KD, Kim GY, Vassiliou CC, Galindo M, Guimaraes AR, Weissleder R, et al. Implantable diagnostic device for cancer monitoring. Biosens Bioelectron 2009;24:3252–7.
Carrara S, Ghoreishizadeh S, Olivo J, Taurino I, Baj-Rossi C, Cavallini A, et al. Fully integrated biochip platforms for advanced healthcare. Sensors (Basel) 2012;12:11013–60.
Taurino I, Magrez A, Matteini F, Forró L, De Micheli G, Carrara S. Direct growth of nanotubes and graphene nanoflowers on electrochemical platinum electrodes. Nanoscale 2013;5:12448–55.
Taurino I, Magrez A, Matteini F, Cavallini A, Forró L, De Micheli G, et al. High-performance multipanel biosensors based on a selective integration of nanographite petals. Nano Lett 2014;14:3180–4.
MacKay S, Wishart D, Xing JZ, Chen J. Developing trends in aptamer-based biosensor devices and their applications. IEEE Trans Biomed Circ Syst 2014;8:4–14.
Schwartz JJ, Thompson JD, Bajaj VS. Aptamer-based sensors, implantable devices and detection system. US patent publication 20160278638, 2016. https://patents.google.com/patent/US20160278638A1/en.
Baj-Rossi C, De Micheli G, Carrara S. Electrochemical detection of anti-breast-cancer agents in human serum by cytochrome P450-coated carbon nanotubes. Sensors (Basel) 2012;12:6520–37.
Aliakbarinodehi N, De Micheli G, Carrara S. Enzymatic and nonenzymatic electrochemical interaction of abiraterone (antiprostate cancer drug) with multiwalled carbon nanotube bioelectrodes. Anal Chem 2016;88:9347–50.
Aliakbarinodehi N, Jolly P, Bhalla N, Miodek A, De Micheli G, Estrela P, et al. Aptamer-based field-effect biosensor for tenofovir detection. Sci Rep 2017;7:44409.
Zhang YS, Busignani F, Ribas J, Aleman J, Rodrigues TN, Shaegh SA, et al. Google glass-directed monitoring and control of microfluidic biosensors and actuators. Sci Rep 2016;6:22237.
Carobene A, Braga F, Roraas T, Sandberg S, Bartlett WA. A systematic review of data on biological variation for alanine aminotransferase, aspartate aminotransferase and γ-glutamyl transferase. Clin Chem Lab Med 2013;51:1997–2007.
Aarsand AK, Røraas T, Bartlett WA, Coşkun A, Carobene A, Fernandez-Calle P, et al. Harmonization initiatives in the generation, reporting and application of biological variation data. Clin Chem Lab Med 2018;56:1629–36.
Ada Health. www.ada.com. Accessed: October 2018.
Babylon Health. www.babylonhealth.com. Accessed: October 2018.
Mediktor Health. www.mediktor.com/corp/. Accessed: October 2018.
AlinIQ. www.corelaboratory.abbott/int/en/offerings/brands/aliniq. Accessed: October 2018.
Pacific Knowledge Systems http://pks.com.au/. Accessed: October 2018.
Tao F, Cheng J, Qi Q, Zhang M, Zhang H, Sui F. Digital twin-driven product design, manufacturing and service with big data. Int J Adv Manuf Technol 2018;94:3563–76.
Brown SA. Principles for developing patient avatars in precision and systems medicine. Front Genet 2016;6:365.
Iansiti M, Lakhani KR. Technology: the truth about blockchain. In: HBR.org, January/February 2017.
Okun S, Wicks P. Digital me: a journey towards personal health and thriving. Biomed Eng Online. https://hbr.org/2017/01/the-truth-about-blockchain. Accessed: October 2018.
Diaz V, Viceconti M, Stroetmann V, Kalra D. Roadmap for the digital patient. http://www.vph-institute.org/upload/discipulus-digital-patient-research-roadmap_5270f44c03856.pdf. Accessed: October 2018.
The virtual physiology Human (VPH) Institute. http://www.vph-institute.org/discipulus.html. Accessed: October 2018.
My Health Avatar. www.myhealthavatar.eu. Accessed: October 2018.
Medical Avatar. www.medicalavatar.com. Accessed: October 2018.
Body Interact. https://bodyinteract.com/. Accessed: October 2018.